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Background:  Coronary  computed  tomography  angiography  (CCTA)  may  be  useful  for noninvasive  follow-
up;  however,  evaluation  of  coronary  stenosis  and  CT number  of  plaque  may  be  inaccurate  under  different
vessel  enhancement  of  contrast  media.  We  examined  the reproducibility  of the  CT number  of repeat  CCTA
using  our  original  CT number-controlling  system  (CTN-CS),  which  selects  contrast  level  by a multiple
regression  equation  using  body  surface  area  and  peak  CT  number  and  peak  time  on timing  bolus  and
during  CCTA.
Methods  and  results:  One  hundred  seventy-two  patients  who  underwent  serial  CCTA  were  prospectively
and  randomly  assigned  to 3 groups.  In  the  ﬁrst  group,  Group  A, the  amount  of contrast  for  the second
CCTA  was  determined  by  CTN-CS  to match  the  intracoronary  CT number  of the  ﬁrst  CCTA.  In Group  B,
each  patient  received  the  same  amount  of  intravenous  contrast  in  both  CCTA  examinations.  In  Group
C,  0.7 mL/mg  body  weight  (BW)  of  contrast  medium  (350  mgI/mL)  was  used  for baseline  and  follow-
up  CCTAs.  The  regression  of repeated  CCTAs  was  the best  in  Group  A  (r = 0.85,  p  < 0.001)  vs.  Group  B
(r  = 0.52,  p <  0.001),  and  Group  C  (r = 0.61,  p  < 0.001).  The  absolute  difference  between  intracoronary  CT
numbers  of the second  and  ﬁrst  CCTA  was  the lowest  in  Group  A (24.8  ±  21.8 HU),  followed  by Group  B
(37.6  ± 26.2  HU;  p <  0.05)  and  Group  C (46.5  ±  34.4 HU;  p < 0.001).
Conclusions:  Using  CTN-CS,  the  difference  of  intracoronary  CT  numbers  of  the second  and  ﬁrst  CCTA was
the  smallest  when  compared  to CCTAs  using  the  same  contrast  volumes  or constant  volumes  per  body
weight.
©  2013  Japanese  College  of  Cardiology.  Published  by Elsevier  Ltd.  All  rights  reserved.ntroduction
Coronary computed tomography angiography (CCTA) is poten-
ially useful for monitoring progression or regression of coronary
rtery disease [1,2] because it is less invasive than imaging modal-
ties such as angioscopy and intravascular ultrasound [3,4].
The  lumen enhancement level of coronary CCTA may  inﬂu-
nce the CT number of the coronary plaque [5]. Excessive
>500 Hounsﬁeld unit (HU)] or low (<200 HU) intracoronary CT
umbers may  cause misdiagnosis of coronary stenosis or plaque [6].
∗ Corresponding author at: 1-12-1, Shio-e, Amagasaki, Hyogo 661-0976, Japan.
el.:  +81 6 6499 3045, fax: +81 6 6497 3225.
E-mail addresses: plaquemap@yahoo.co.jp, epubook@yahoo.co.jp (S. Komatsu).
914-5087/$ – see front matter © 2013 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2013.03.004For comparison of serial CCTA, different intracoronary CT numbers
in each CCTA might interfere with accurate analysis.
In general, the amount of contrast used is approximately
0.7–1 mL/kg body weight (BW) [7]. However, the range of intra-
coronary CT numbers spans approximately 200 HU, and the
standard deviation of CT number is >50 HU [7] on CCTA with con-
trast volume determined by BW,  body mass index (BMI) [8], or
body surface area (BSA) [9]. We  have reported the principles and
accuracy of a novel CT number-controlling system, CTN-CS, for pre-
dicting intracoronary CT number of a speciﬁed amount of contrast
media and for predicting the optimal amount of contrast needed to
reach a targeted intracoronary CT number [10]. This system might
provide more accurate analysis by targeting the previous intracoro-
nary CT number at follow-up CCTA.
In this paper, we examined the reproducibility of intracoro-
nary CT number from baseline to follow-up CCTA using CTN-CS,
vier Ltd. All rights reserved.
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omparing the CTN-CS evaluations with those using the same
mount of contrast and those using the same ratio of contrast per
ilogram BW.
aterials and methods
tudy  population
A  total of 172 patients who underwent serial CCTAs for clinical
easons were prospectively enrolled. Patients were referred for the
rst CCTA because of suspected (n = 108) or known (n = 64) coronary
rtery disease.
The  reason for a second CCTA was to follow up after percuta-
eous coronary intervention (n = 114) and to check for progression
n patients with worsening chest pain after initiation of medica-
ion for coronary heart disease (n = 58) that was detected on the
rst CCTA.
Enrolled patients were randomly assigned to 3 groups.
Group A: the amount of contrast medium (CM) at the second CCTA
was  determined by CTN-CS according to the CT number of the
ascending  aorta at the level of coronary artery in the ﬁrst CCTA.
Group  B: the same amount of CM was injected at the same rate in
each CCTA.
Group C: 0.7 mL/kg BW of CM was used in each CCTA. BW was
measured  before each CCTA.
According to our previous report [10], a valid time-density curve
TDC) was found in 88.9% of individuals, and CTN-CS can be applied
ith valid TDC. As a patient with invalid TDC is unable to apply
o CTN-CS [10], the number of patients in Group A and Group B
ere established considering the ratio of application in order to be
imilar to the number of Group C.
This study was approved by the local ethics committee, and
ll patients provided written informed consent. Clinical exclusion
riteria for CCTA were allergy to CM,  renal insufﬁciency (glomeru-
ar ﬁltration rate, <60 mL  min−1·1.73 mm−2), pregnancy, congenital
eart disease, limited left ventricular function (ejection fraction less
han 50%), or coronary artery bypass graft.
Patients received an oral beta-blocker (25 mg  atenolol;
straZeneca, Osaka, Japan) 120 min  before CCTA and 0.3 mg  of sub-
ingual nitroglycerine 5 min  before CCTA. Heart rate was  controlled
etween 55 and 65 bpm with additional administration of intra-
enous beta-blocker (2–10 mg  propranolol; AstraZeneca).
canning  protocol
Multidetector row (MD)CT was performed using a 64-detector
ightspeed VCT CT scanner (GE Healthcare, Milwaukee, WI,  USA)
ith electrocardiographic (ECG) gating and Advantage Worksta-
ion 4.3 software (GE Healthcare). The scan sequence included scout
canogram, timing bolus, and coronary angiography.
CCTA was performed with prospective ECG triggering (Snapshot
ulse, GE Healthcare) with the following parameters: slice acqui-
ition, 64 mm × 0.625 mm (40-mm volume coverage); 75% of the
R interval with 0–100 ms  of padding; rotation time, 350 ms;  tem-
oral resolution, 175 ms;  tube potential, 120 kV; and tube current,
50–680 mA.  If blurring artifacts occurred with the timing bolus,
atients underwent CCTA with retrospective ECG gating. ECG mod-
lation of 40–80% of the RR interval was used because prospective
riggering had not been introduced. The pitch was approximately
.2–0.3.
CM (350 mgI/mL; Omnipaque 350; Daiichi Pharmaceutical Co,
td, Tokyo, Japan) was injected into an antecubital vein using a
ual-head injector system (Dual Shot GX; Nemoto Kyorindo Co, Ltd,diology 62 (2013) 82–86 83
Tokyo, Japan) programmed with CTN-CS during the timing bolus
and CCTA at 4 mL/s, with a 40 mL  saline chaser. CM (5 mL) with
40 mL  of saline chaser was used as the timing bolus to determine
the circulation time of the enhanced scan. Sequential scans were
obtained every 2 s from 10 to 40 s after the timing bolus. The region
of interest (ROI) was located in the ascending aorta, and the TDC
was determined. The peak time was  identiﬁed, and the absolute
value of the CT number of the ascending aorta at the peak time was
measured at the ROI.
At  the ﬁrst CCTA, an optimal CT number between 250 and
430 HU in Groups A and B was targeted by CTN-CS, as recently
described in detail [10]. The CTN-CS program is based on a sim-
ple equation for best-described CT number by multiple regression
analysis. An injector equipped with CTN-CS can predict the contrast
volume for a targeted intracoronary CT number and the intracoro-
nary CT number for a given contrast volume [10].
In Group A, CTN-CS was  used again for the second CCTA to target
the intracoronary CT number of the ﬁrst CCTA. The amount of CM
required to match the intracoronary CT number of the ﬁrst CCTA
was determined for the second CCTA by CTN-CS. In Group B, CM
(5 mL)  was used as a timing bolus in all patients to analyze the
circulation time of the enhanced scan while the same volume of CM
was administered with the same speed as the ﬁrst CCTA (4 mL/s).
Tube potential and current were also set to the same value as that
of the ﬁrst CCTA.
The  scan was started manually by monitoring and tracking
consecutive contrast enhancement of the right pulmonary artery,
pulmonary vein, and left atrium at 2-s intervals from 10 s after
contrast delivery in both groups.
TDC was  graded as follows: (1) valid, TDC showing a unimodal
curve and in which the peak time and peak CT number were mea-
surable and (2) invalid, TDC showing a ﬂat or multimodal curve
and/or in which the peak time and peak CT number were not
determined [10]. Patients with invalid TDCs underwent CCTA using
0.7 mL/kg BW of CM,  but they were excluded from analysis. The
intracoronary CT number was calculated as the mean value of the
vessel CT numbers of the left main and proximal right coronary
arteries after CCTA. Calciﬁcation, plaques, and stents were carefully
excluded from the measurement of calculation of intracoronary CT
number.
In Group C, 0.7 mL/kg BW CM was used for the ﬁrst CCTA. CCTA
was performed after a timing bolus of 5-mL CM with a 40-mL saline
chaser to determine the circulation time of the enhanced scan. For
the second CCTA, BW was  re-measured and 0.7 mL/kg BW of CM
was again used.
Absolute  values of the differences in CT numbers
The absolute values of the differences in intracoronary CT num-
bers between the second and ﬁrst CCTA of Group A were compared
with those of Group B and Group C, respectively.
The absolute values of the differences in intracoronary CT num-
bers between the second and ﬁrst CCTA was calculated by the
formula:
|(intracoronary CT number in 2nd session)
−  (intracoronary CT number in 1st session)|
Statistical analysisStatistical analysis was performed using SPSS 17.0 (SPSS Inc,
Chicago, IL, USA). Data are expressed as mean ± SD. Correlations
of intracoronary CT number in the ﬁrst and second CCTA in each
group were analyzed. The absolute values of the differences in
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ntracoronary CT numbers at second and ﬁrst CCTA were com-
ared by one-way analysis of variance. p-Values were generated
y ANOVA using the Dunnett Test for multiple comparisons to
roup A.
esults
ollow-up and timing bolus
Study design is shown in Fig. 1. All patients underwent CCTA suc-
essfully, and no patient declined follow-up CCTA. Eight and seven
atients were excluded from Group A and Group B, respectively,
ecause of invalid TDCs at the ﬁrst CCTA. Patient characteristics,
onditions of the timing bolus, and CT number in all groups at the
rst CCTA are shown in Table 1. No patient had acute myocardial
nfarction or acute heart failure during the follow-up period. Among
he remaining 105 patients, no patient had invalid TDC at the sec-
nd CCTA. The mean follow-up periods of Group A (n = 53), Group B
n = 52), and Group C were 9.6 ± 3.4, 9.5 ± 3.9, and 9.9 ± 3.9 months,
espectively (n.s.). There was no difference in BSA or peak time and
T number of timing bolus between Group A and Group B (Table 1),
hich related to intracoronary CT number [10]. The change in BW
n Group C was −1.0% ± 7.2%. The peak times of the timing bolus
f the ﬁrst and second CCTAs were the same in only 15, 10, and 12
atients (28.3%, 19.2%, and 23.1%) in Group A, Group B, and Group
, respectively (Table 1).
ig. 1. Study protocol. CTN-CS, computed tomography number-controlling system;
CTA, coronary computed tomography angiography; TDC, time-density curve; BW,
ody weight; CM,  contrast medium.
able 1
atients’ condition of timing bolus and CT number in Group A and Group B at ﬁrst CCTA.
Group A 
n 53 
Gender  male, % 37 (69.8%) 
Body  surface area (m2) 1.55 ± 0.17 
Follow-up  period (months) 9.6 ± 3.4 
Test  peak time (second) 20.2 ± 3.2 
Test  peak CT number (HU) 112 ± 23 
Patients  of same test peak time at 1st and 2nd CCTA, % 15 (28.3%)
Amount  of contrast media at 1st CCTA (mL) 30 ± 8 
CT number at 1st session (HU) 341 ± 56 
T, computed tomography; CCTA, coronary computed tomography angiography.
* Group A vs. Group C and Group B vs. Group C.diology 62 (2013) 82–86
Correlation analysis of serial examinations by group
There was  excellent correlation in intracoronary CT number
between the ﬁrst (x) and second (y) CCTA examinations in Group
A (y = 0.95x + 24.5; r = 0.85, p < 0.001) (Fig. 2A). There was mod-
erate correlation in intracoronary CT number between ﬁrst (x)
and second (y) CCTA in Group B (y = 0.59x + 128; r = 0.52, p < 0.001)
(Fig. 2B), and there was  moderate correlation between intracoro-
nary CT numbers of CCTA at ﬁrst (x) and second (y) exam in Group C
(y = 0.58x + 169; r = 0.61, p < 0.001) (Fig. 2C). The slope of the correla-
tion curve was ∼1 for Group A and <1 for Group B and Group C. The
absolute difference in intracoronary CT numbers from the second
to ﬁrst CCTA was lower in Group A than in Group B (24.8 ± 21.8 HU
vs. 37.6 ± 26.2 HU, mean ± SD, p < 0.01) (Fig. 3). The absolute dif-
ference in intracoronary CT numbers between the second and
ﬁrst CCTA was lower in Group A than in Group C (24.8 ± 21.8 HU
vs. 46.5 ± 34.4 HU, mean ± SD, p < 0.001) (Fig. 3). In Group A, the
correlation coefﬁcient was  strongest, and there was moderate cor-
relation between the amount of CM at the ﬁrst (x) and second (y)
CCTA (y = 0.55x + 13.7; r = 0.62, p < 0.001) (Fig. 4).
Discussion
This study indicates that CTN-CS provides excellent correlation
in CT numbers between baseline and follow-up CCTA examina-
tions. Follow-up CCTA can be used in many situations involving
both diagnosis [11] and treatment [12] of coronary artery disease
and heart transplantation [13]. CT numbers of plaques may  be as
high as intracoronary CT numbers and quantitative and qualitative
analysis of plaque regression or progression in CCTA may be reliable
only under similar intracoronary CT numbers. The optimal vascu-
lar CT number for detection of coronary artery stenosis on CCTA
with 64-MDCT is approximately 350 HU [6]. Many methods of con-
trast delivery are used between 0.7 and 1 mL/kg BW [7,8,14,15];
however, few have succeeded in optimizing intracoronary CT num-
bers. Recently, studies have reported evaluation of plaque changes
in the coronary artery by CCTA; however, the amount of CM used
was roughly described as 60–100 mL,  and information regarding
intracoronary CT number was truncated [14].
The range of CT numbers based on BW,  BMI, or BSA has been
approximately 200 HU in the studied population [7–9]. In patients
undergoing serial CCTAs in Group C, the result was slightly better,
and the difference in CT number between baseline and follow-up
CCTA averaged 46.5 HU and ranged to approximately 170 HU. How-
ever, the intracoronary CT number in Group C averaged 430 HU,
which is higher than the optimized CT number for diagnosing coro-
nary artery disease and plaque [6].
Although we agree that all scan conditions of CCTA should be
recorded [16], we  also found that using the same amount of CM
did not contribute to reproducibility of intracoronary CT numbers.
Group B Group C p-Value
52 52 n.s.
37 (71.1%) 35 (67.7%) n.s.
1.57 ± 0.16 1.56 ± 0.18 n.s.
9.5 ± 3.9 9.9 ± 3.9 n.s.
20.1 ± 3.5 20.2 ± 3.3 n.s.
111 ± 26 114 ± 25 n.s.
10 (19.2%) 12 (23.1%) n.s.
28 ± 8 41 ± 8 p < 0.001*
339 ± 47 430 ± 67 p < 0.001*
S. Komatsu et al. / Journal of Cardiology 62 (2013) 82–86 85
Fig. 2. Correlation of intracoronary computed tomography (CT) numbers between the ﬁrst and second coronary computed tomography angiography (CCTA) using the CT
n ium (CM) (Group B), and with 0.7 mL/kg body weight contrast medium (Group C).
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Fig. 3. Absolute value of the difference in intracoronary computed tomography (CT)
number between the second and ﬁrst coronary computed tomography angiogra-umber-controlling system (CTN-CS) (Group A), with same amount of contrast med
he difference in CT number of both the ﬁrst and the second CCTA
veraged 37.6 HU and ranged to approximately 120 HU in Group B.
The required amount of CM varied by up to 20 mL  between base-
ine and follow-up examinations in Group A (Fig. 4). This may  have
een due to changes in hemodynamics based on time of the day,
edication, or condition of the disease during the time between
he 2 tests. Nonetheless, there was strong correlation between
he intracoronary CT numbers at both the ﬁrst and second CCTA
n Group A, suggesting that CTN-CS further improved the repro-
ucibility of CT number on both occasions.
Weininger et al. have demonstrated that CT-related, patient-
elated, and contrast-related factors are involved in contrast
nhancement [17]. Unfortunately, it would be overly invasive to
easure the effects of all of the variables in order to guaran-
ee reproducibility of CT number in cases of repeated CCTA. Our
revious report [10] showed that there was excellent correlation
etween targeted and measured CT number (y = 1.00x, r = 0.85,
 < 0.0001) for randomly targeted CT numbers between 250 and
30 HU in 112 patients using CTN-CS. In these results, both peak
ime and peak CT number of timing bolus may  reﬂect all of the
emodynamic parameters at the time. To simplify and make con-
tant contrast-related factors, 350 mgI/mL of CM was injected at
 ﬁxed rate of 4 mL/s with a 40-mL saline chaser [10]. CTN-CS
phy  (CCTA) (HU). The absolute difference in intracoronary CT number between the
second and ﬁrst CCTA was lower in Group A than in Group B (24.8 ± 21.8 HU vs.
37.6 ± 26.2 HU, mean ± SD, p < 0.05). The absolute difference in intracoronary CT
number between the second and ﬁrst CCTA was lower in Group A than in Group
C  (24.8 ± 21.8 HU vs. 46.5 ± 34.4 HU, mean ± SD, p < 0.001).
86 S. Komatsu et al. / Journal of Car
Fig. 4. Comparison of amount of contrast medium (350 mgI/mL) between serial
coronary computed tomography angiography (CCTA) examinations using the com-
puted tomography number-controlling system in Group A. There was  moderate
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[orrelation  between the amount of contrast used in the ﬁrst (x) CCTA and second
y) CCTA (y = 0.55x + 13.7, r = 0.62, p < 0.001).
rograms may  play a role in accurate monitoring of changes in
oronary stenoses and plaques.
tudy limitations
CTN-CS can be used only for patients with valid TDC of the
iming bolus, which requires a smaller amount of CM than that
equired for bolus tracking. We  implied the usefulness of CTN-CS
or evaluating plaque change because the intracoronary CT num-
ers of the follow-up CCTA examinations were close to baseline
ithout direct examination. The CT number of a plaque on a repeat
CTA performed immediately after an initial CCTA may  be overesti-
ated because of plaque enhancement, and repeat CCTA performed
ithin a few days only to indicate a reproducible CT number of a
laque would be ethically unacceptable due to potential risks of
adiation and contrast doses.
onclusions
Obtaining similar intracoronary CT numbers on serial CCTA
xaminations is not always possible, even with the same amount
f CM.  CTN-CS can be used to provide better reproducibility of CT
umber for repeated CCTAs in patients who are expected to beneﬁt
rom follow-up CCTA examinations.onﬂict of interest
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